SPDR S&P World ex US ETF (the Fund) seeks to replicate as closely as possible total return performance of the S&P/Citigroup BMI World Ex US Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in developed countries outside the United States. The Index is float adjusted, meaning that only those shares publicly available to investors are included in the Index calculation. The Fund uses a passive management strategy designed to track the price and yield performance of the Index. The Fund's investment manager is SSgA Funds Management, Inc.
Basic Details
Issuer SSgA
Fund NameSPDR Portfolio Developed World ex-US ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:SPDW
Inception Date4/20/2007
Fund ManagerMichael Feehily, Karl Schneider, Kala ODonnell
Phone+1-866-7872257
Fund Focus
Asset ClassEquity
BenchmarkS&P Developed Ex-U.S. BMI Index
CategoryBroad Equity
FocusBroad Equity
Development LevelBlended Development
RegionGlobal Ex-U.S.
Fund Statistics
Assets Under Management$5.95 billion
Average Daily Volume$1.39 million
Discount/Premium0.10%
ETF Expenses
Management Fee0.04%
Other Expenses0.00%
Total Expenses0.04%
Fee Waiver0.00%
Net Expenses0.04%
Administrator, Advisor and Custodian
AdministratorSSGA Funds Management, Inc.
AdvisorSSgA Funds Management, Inc.
CustodianState Street Bank and Trust Company
DistributorState Street Global Advisors Funds Distributors, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerJane Street
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.
